Search

News

Ascenion GmbH, technology transfer partner of the Max Delbrück Center for Molecular Medicine (MDC), has supported the conclusion of an agreement between the MDC and Fate Therapeutics, Inc.

The German Association for Certification has confirmed that Ascenion complies with the quality management system requirements of European norm DIN EN…

Don’t miss your chance to secure a spot at next year’s BioVaria, 27 – 28 April 2020 in Munich! Application for European startups is now open until 14

The NUVISAN group, an international service provider for clinical studies, contract development and manufacturing (CRO/CDMO) with headquarters in…

[Translate to English:]

Ascenion’s portfolio company Photonion GmbH offers innovative mass spectrometry systems that allow a more detailed analysis of air pollutants,…

[Translate to English:]

Learn about the milestones we reached together with our partners in 2018, the revenues we generated and interesting emerging trends. The key points at…

Should public research institutes and universities receive equity in start-ups founded to commercialize their intellectual property? And if so, how…

New website online

Check out our new website design to help you find what you need:
 

  • Information about us and our services
  • Technology offers from our partner…
[Translate to English:]

New drug delivery system to enable needle-free application of drugs

More than 1,300 delegates from 35+ countries, such as big pharma, emerging and small biotech, diagnostics companies, pre-seed, seed and Series-A…

Confidential disclosure agreements, material transfer agreements and term sheets – all these contracts have to be closed during the planning phase of…

This year’s innovation prize from the Metropolregion Mitteldeutschland goes to a team that has brought a novel anti-tuberculosis compound all the way…

Be part of Munich’s vibrant bioentrepreneurial ecosystem and join the BioEntrepreneurship Summit on 15 – 16 October 2019. The event is organized by…

Ascenion’s portfolio company Berlin Cures has initiated a Phase IIa clinical study with its lead compound BC 007. The two-armed, randomized,…


BioVaria Start-up Awards go to ISD Immunotech and Mindpax.me
13 May 2019, Munich, Germany – The 12th BioVaria welcomed over 250 life-science…

Events

Prague, Czech Republic

Ankara, Turkey

BIO-Europe 2026

Cologne, Germany